![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 17, 2007 3:43:08 AM
It appeared imminent to me from the onset of DNAPrint's emergence and development as the true visionary of pharmacogenomics, theranostics, and all-around biotechnology achievements...and that's when I made my initial comments. Tony Frudakis deserves accolades beyond multi-achievements at every developmental stage of DNAPrint. Let's not forget the Management, CEO Richard Gabriel, etc., who have also endeavored multiple-business tasks in behalf of the shareholders, in my viewpoint, in gratitude to a remarkable management staff! - That is MHO! If the high status operations change, I will be the first to deny...otherwise...Let's Roll!!
Ann
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM